insights_auto
为什么 EVT 下跌了 2.28%?
深入探索chevron_right
EVT:FRA
Evotec SE
€2.83
arrow_downward
-2.28%(-0.066) 1 天
10月9日, GMT+2 22:00:00 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 EVT 生成关键数据洞见…
开盘价
€2.80
最高价
€2.85
最低价
€2.80
市值
4.88亿
平均成交量
4653.00
成交量
2400.00
52 周最高价
€7.49
52 周最低价
€2.73
每股收益
-€1.11
流通股数
1.49亿
员工人数
4461
开盘价
€2.80
最高价
€2.85
最低价
€2.80
市值
4.88亿
平均成交量
4653.00
成交量
2400.00
52 周最高价
€7.49
52 周最低价
€2.73
每股收益
-€1.11
流通股数
1.49亿
员工人数
4461
新闻报道
来自网络来源和新闻合作伙伴
AD HOC NEWS
·
18小时前
Evotec stock holds at EUR 2.80 in a week of leadership change
AD HOC NEWS
·
1天前
Evotec stock sits at EUR 2.80, 63.6 percent below its high
资料
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
Evotec SE简介